Cited by 179Mast cells and histamineCoagulation, Bradykinin, Polyphosphates, and AngioedemaImmunodeficiency and Autoimmune Disorders

Hereditary Alpha Tryptasemia

Open access
Lyons, Jonathan J.·2018·Immunology and Allergy Clinics of North America

Abstract

Hereditary alpha tryptasemia is an autosomal dominant genetic trait caused by increased germline copies of TPSAB1 encoding alpha-tryptase. Individuals with this trait have elevated basal serum tryptase, and may present with associated multisystem complaints. Both basal serum tryptase levels and severity of clinical symptoms display a gene-dose relationship with TPSAB1, whereby higher tryptase levels and greater symptom severity are correlated with increasing numbers of alpha-encoding TPSAB1. As the functional effects of increased basal serum tryptase and/or altered tryptase gene expression are elucidated, greater insights will be gained into the symptoms associated with hereditary alpha tryptasemia and their potential therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.iac.2018.04.003

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In some cases, patients with HαT do present with a clinical picture dominated by mediator-related symptoms (i.e., vibratory urticaria, flushing, abdominal cramps, headache, dysautonomia, etc.).

    “In some cases, patients with HαT do present with a clinical picture dominated by mediator-related symptoms (i.e., vibratory urticaria, flushing, abdominal cramps, headache, dysautonomia, etc.) [15,16,45].”

    From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [15]

    The Associated clinical features section (page unavailable) reports flushing, vibration-triggered skin symptoms, gastrointestinal complaints, and symptoms suggestive of autonomic dysfunction in people with HαT. It calls the skin symptoms suggestive of mast-cell mediator release, but says the episodes were not sufficiently studied to confirm they were mast-cell-related. The claim’s characterization of the clinical picture as dominated by mediator-related symptoms is therefore stronger than the source supports. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Various clinical conditions, including dysautonomia with postural orthostatic hypotension, flushing, gastrointestinal hypomotility, joint hypermobility, vibratory urticaria, irritable bowel syndrome, chronic musculoskeletal pain, retained primary dentition, and allergic disorders, were initially reported in patients with hereditary alpha-tryptasemia.

    “Initially, various clinical conditions, including dysautonomia with postural orthostatic hypotension, fl ushing, gastrointestinal hypomotility, joint hypermobility, vibratory urticaria, irritable bowel syndrome, chronic musculoskeletal pain, retained primary dentition, and allergic disorders, were reported in patients with H a T. 120,121,125-127”

    From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [125]

    The Associated clinical features section (page unavailable) reports orthostatic hypotension and other autonomic symptoms, flushing, joint hypermobility, IBS, chronic pain, retained primary dentition, and allergic reactions in people with hereditary alpha-tryptasemia. It also reports urticaria and vibration as a trigger for cutaneous symptoms, but does not clearly identify vibratory urticaria. The copy does not report gastrointestinal hypomotility or specify that the chronic pain was musculoskeletal. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Hereditary alpha tryptasemia (HαT) is characterized by an increased alpha coding TPSAB1 copy number and is associated with a baseline tryptase value above 8 ng/mL.

    “A genetic trait, hereditary alpha tryptasemia, characterized by an increased alpha coding TPSAB1 copy number is associated with a baseline value above 8 ng/mL.”
  • HαT may account for elevated serum tryptase in the absence of clonal mast cell disorders.

    “Hereditary alpha-tryptasemia (HαT) is an autosomal dominant genetic trait of an increased copy number of the alpha-coding (of ≥2) TPSAB1-gene [15,16], which may account for elevated serum tryptase in the absence of clonal mast cell disorders.”
  • The growing knowledge of HαT, a germline condition causing increase in BST, has not fully elucidated clinical consequences.

    “growing knowledge of hereditary alpha-tryptasemia (HαT), a germline condition causing increase in BST with not fully elucidated clinical consequences (4–6).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lyons, J. J.
Affiliations
National Institutes of Health (US)
Corresponding author
Lyons, Jonathan J.
Venue
Immunology and Allergy Clinics of North America
Publisher
Elsevier BV
Published
2018-08
Volume
38
Issue
3
Pages
483-495
ISSN
0889-8561 (ISSN-L)
OpenAlex
W2805441868
Cited by
179
References
40
Citations by year
2026: 23 · 2025: 23 · 2024: 20 · 2023: 23 · 2022: 20 · 2021: 39 · 2020: 15 · 2019: 14 · 2018: 1
FWCI
1.76
Type
journal article
Language
en
Open access
Locations
  • Immunology and Allergy Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Allergy and Infectious Diseases
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Genetics › Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Keywords
hereditary alpha-tryptasemia, TPSAB1, autosomal dominant inheritance, gene dosage, serum tryptase, multisystem symptoms
MeSH terms
Connective Tissue, Gene Expression Regulation, Genes, Dominant, Genotype, Humans, Hypersensitivity, Immediate, Immunoglobulin E, Mast Cells, Mastocytosis, Skin, Disease Progression, Gene Dosage, Gene Duplication, Quantitative Trait Loci, Tryptases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review